Clivatuzumab
Clivatuzumab is a humanized anti-myxinomab, which can target the MUC1 epitope highly expressed on the surface of most pancreatic cancer cells, and has a good therapeutic effect on a variety of tumor cells.
Product Specifications
CAS Number
1622075-09-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB0523-100 1x 100 µL
AFP (Alpha Fetoprotein) (C2), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details K1528805 3x 1.0 µg
OR6K3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 15410061 1.0 µg DNA
CCNL1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
252365 100 µg
TAGLN (Transgelin, DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10)
Sign In for Pricing
View Details